Among 5 analysts covering Fluidigm (NASDAQ:FLDM), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Fluidigm had 21 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Fluidigm Corporation (NASDAQ:FLDM) earned “Hold” rating by Piper Jaffray on Thursday, August 3. On Monday, September 4 the stock rating was maintained by Piper Jaffray with “Hold”. On Friday, August 5 the stock rating was maintained by Mizuho with “Buy”. The stock has “Hold” rating by Mizuho on Sunday, August 9. The firm has “Hold” rating given on Wednesday, December 20 by Cowen & Co. The rating was maintained by Mizuho with “Neutral” on Friday, August 7. The stock has “Buy” rating by Mizuho on Friday, February 5. On Thursday, August 27 the stock rating was maintained by Maxim Group with “Hold”. Zacks upgraded Fluidigm Corporation (NASDAQ:FLDM) on Friday, August 21 to “Sell” rating. As per Wednesday, August 26, the company rating was initiated by Cantor Fitzgerald. See Fluidigm Corporation (NASDAQ:FLDM) latest ratings:
20/12/2017 Broker: Cowen & Co Rating: Hold New Target: $7.25 Maintain
04/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $4.4 Maintain
Gevo, Inc. (GEVO) formed triangle with $0.50 target or 7.00% above today’s $0.47 share price. Gevo, Inc. (GEVO) has $9.32 million valuation. The stock increased 8.99% or $0.0387 during the last trading session, reaching $0.4692. About 590,375 shares traded. Gevo, Inc. (NASDAQ:GEVO) has declined 85.24% since February 8, 2017 and is downtrending. It has underperformed by 101.94% the S&P500.
Analysts await Gevo, Inc. (NASDAQ:GEVO) to report earnings on April, 4. They expect $-0.26 EPS, up 77.19% or $0.88 from last year’s $-1.14 per share. After $-0.36 actual EPS reported by Gevo, Inc. for the previous quarter, Wall Street now forecasts -27.78% EPS growth.
Among 2 analysts covering Gevo (NASDAQ:GEVO), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Gevo has $12 highest and $5 lowest target. $12’s average target is 2457.54% above currents $0.4692 stock price. Gevo had 6 analyst reports since August 19, 2015 according to SRatingsIntel. The stock has “Buy” rating by Rodman & Renshaw on Wednesday, August 19. The firm earned “Buy” rating on Wednesday, July 26 by H.C. Wainwright. The rating was maintained by H.C. Wainwright with “Buy” on Friday, August 4. H.C. Wainwright initiated Gevo, Inc. (NASDAQ:GEVO) rating on Wednesday, August 19. H.C. Wainwright has “Buy” rating and $5.50 target. The stock has “Neutral” rating by H.C. Wainwright on Tuesday, January 9. The firm earned “Buy” rating on Friday, January 13 by Rodman & Renshaw.
Since October 16, 2017, it had 11 buys, and 0 insider sales for $2.96 million activity. On Tuesday, January 16 LEVIN CAPITAL STRATEGIES – L.P. bought $5,928 worth of Fluidigm Corporation (NASDAQ:FLDM) or 887 shares.
Investors sentiment increased to 1.58 in Q3 2017. Its up 0.37, from 1.21 in 2017Q2. It improved, as 7 investors sold Fluidigm Corporation shares while 17 reduced holdings. 8 funds opened positions while 30 raised stakes. 32.41 million shares or 37.16% more from 23.63 million shares in 2017Q2 were reported. Jacobs Levy Equity invested 0.02% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Citigroup Incorporated, a New York-based fund reported 97 shares. Cornerstone Limited Company has 0% invested in Fluidigm Corporation (NASDAQ:FLDM). Connor Clark & Lunn Investment has invested 0% in Fluidigm Corporation (NASDAQ:FLDM). Renaissance Technology Ltd Liability Corp reported 0% stake. Bank & Trust Of America De has 1,785 shares for 0% of their portfolio. Wells Fargo And Mn holds 22,142 shares or 0% of its portfolio. Healthcare Value Cap Lc reported 3.64% stake. American Group Inc Inc reported 0% in Fluidigm Corporation (NASDAQ:FLDM). Schwab Charles Mgmt Incorporated accumulated 56,000 shares. Northern Tru stated it has 410,585 shares. State Street Corp invested in 0% or 511,164 shares. Voya Ltd Limited Liability Company stated it has 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Blackrock stated it has 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Wasatch Incorporated reported 252,890 shares stake.
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. The company has market cap of $230.45 million. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. It currently has negative earnings. The firm also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules.
The stock increased 2.81% or $0.1627 during the last trading session, reaching $5.9627. About 27,243 shares traded. Fluidigm Corporation (NASDAQ:FLDM) has declined 36.51% since February 8, 2017 and is downtrending. It has underperformed by 53.21% the S&P500.